Trials / Sponsors / Kevin Kim, MD
Kevin Kim, MD
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Mirdametinib in Patients With Advanced NF1-mutant Melanoma Advanced Unresectable Melanoma, Metastatic Melanoma | Phase 2 | 2025-10-13 |